All research
2026-07-15 PubMed

Spore-Forming Probiotic Biomaterials Proposed for Targeted Gut Microplastic Biodegradation

Spore-Forming Probiotic-Embedded Biomaterials for Targeted Gut Microplastic Biodegradation.

Background

Exposure to microplastics (MPs) in the gut is a growing concern, known to compromise gut barrier integrity, disrupt microbial homeostasis, and impair host immunity, ultimately accelerating mucosal dysfunction and disease progression. Current strategies for plastic biodegradation, effective in environmental settings, face significant limitations within the harsh physiological constraints of the gut. Spore-forming probiotic (SFP) strains offer a promising avenue due to their intrinsic resilience and diverse metabolic capacities for plastic degradation, but their functional deployment is hindered by spatial dilution, enzyme instability, and insufficient polymer-microbe contact.

Study Design

This perspective article outlines a novel conceptual framework for addressing gut microplastic accumulation by leveraging spore-forming probiotics (SFPs). The authors discuss strategies for embedding SFPs into engineered biomaterial platforms, specifically focusing on microcapsules, hydrogels, and polymer films. This approach aims to overcome current limitations by localizing probiotic activity, regulating their germination and secretion dynamics, and mediating controlled interactions with microplastics directly within the challenging gut-physiological conditions.

Results

The authors propose that SFP-integrated biomaterials can effectively circumvent the feasibility restrictions faced by conventional plastic biodegradation mechanisms within the gut. They detail the mechanistic basis of SFP-mediated microplastic degradation, which includes enzymatic, biosurfactant-mediated, and oxidative pathways. These pathways leverage the intrinsic resilience and diverse metabolic capabilities of SFPs. The proposed biomaterial design strategies are intended to ensure optimized targeted activity.

The core proposal is that embedding SFPs into engineered biomaterials will enable controlled microbe-microplastic interactions, optimizing targeted activity within the gut by localizing probiotic function and regulating their dynamics. This controlled environment is crucial for effective degradation, ensuring sufficient polymer-microbe contact and enzyme stability, which are often lacking in free probiotic applications.

Key Findings

  • Gut microplastic exposure compromises gut barrier integrity, microbial homeostasis, and host immunity.
  • Spore-forming probiotics (SFPs) possess intrinsic resilience and diverse plastic degradation capacities.
  • Embedding SFPs into engineered biomaterials (microcapsules, hydrogels, films) can localize activity and regulate dynamics.
  • Proposed SFP-mediated degradation mechanisms include enzymatic, biosurfactant-mediated, and oxidative pathways.
  • Conceptual framework aims to enable controlled microbe-MP interactions for targeted gut biodegradation.

Why It Matters

This conceptual framework offers a groundbreaking strategy for developing future SFP-assisted gut MP therapeutics, potentially transforming how we address microplastic-induced gut damage. By proposing engineered biomaterials to localize and regulate probiotic activity, this work outlines a path to overcome the physiological barriers that currently limit effective gut detoxification. This could lead to novel protocols involving oral delivery of encapsulated SFPs, providing a targeted and efficient method to mitigate the detrimental effects of microplastics on gut health and immunity, moving beyond general probiotic supplementation to a specific, engineered intervention.


microplastics gut-health probiotics biomaterials biodegradation gut-microbiome
Source: pubmed:42453354 · Ingested 2026-07-15 · Digest: gemini-2.5-flash